Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

858
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
858

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of Administered Activity for <sup>64</sup> Cu-SAR-bisPSMA PET Imaging in Primary Prostate Cancer: Results from a Phase I Retrospective Study (PROPELLER Sub-study).

World journal of nuclear medicine·2026
Same author

Feasibility and efficacy of left bundle branch area pacing guided by modified chest lead 1.

Journal of electrocardiology·2026
Same author

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

Nature communications·2026
Same author

Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.

Frontiers in artificial intelligence·2026
Same author

Dissociated Purkinje potential as an active driver of multifocal Purkinje ventricular tachycardia: A case report.

HeartRhythm case reports·2026
Same author

Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery.

Science translational medicine·2026

Related Experiment Video

Updated: Jun 12, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K

Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck Cancer.

Daniel A Ruiz-Torres1,2,3, Michael E Bryan1,2, Shun Hirayama1,2

  • 1Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA.

Medrxiv : the Preprint Server for Health Sciences
|September 24, 2024
PubMed
Summary

Tertiary Lymphoid Structures (TLS) are more prevalent in head and neck squamous cell carcinoma (HNSCC) patients who respond to immune checkpoint blockade (ICB). TLS density predicts ICB response and survival, potentially outperforming PD-L1 Combined Positive Score (CPS).

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

305
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

Related Experiment Videos

Last Updated: Jun 12, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

305
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

Area of Science:

  • Immunology
  • Oncology
  • Biomarker Discovery

Background:

  • Immune checkpoint blockade (ICB) is a standard treatment for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), but its efficacy is limited.
  • Current predictive biomarkers, such as PD-L1 Combined Positive Score (CPS), have limited predictive value due to a lack of cell-type differentiation.
  • Tertiary Lymphoid Structures (TLS) show promise as a more accurate predictor of ICB response, but their role in HNSCC requires further investigation.

Purpose of the Study:

  • To investigate the composition, size, and spatial biology of TLS in HNSCC.
  • To evaluate the association between TLS characteristics and response to ICB.
  • To explore the potential of TLS as a predictive biomarker for ICB therapy in HNSCC.

Main Methods:

  • Multi-immunofluorescence (mIF) staining was used to characterize immune cells, tumor cells, and immunoregulatory molecules in pre-ICB HNSCC tumor tissues from responders and non-responders.
  • Spatial metrics of immune cells and TLS were analyzed.
  • A machine learning model was employed to assess the predictive value of these metrics for ICB response.

Main Results:

  • Responders exhibited a higher density of B lymphocytes (CD20+) compared to non-responders.
  • TLS density positively correlated with mIF and pathologist identification, trending higher in responders.
  • The presence of TLS near the tumor was associated with improved overall and progression-free survival, with TLS density achieving 80% accuracy in predicting ICB response via a machine learning model.

Conclusions:

  • Immune cell densities and TLS spatial location are critical in the HNSCC immune response to ICB.
  • TLS show potential as a superior predictive biomarker for ICB response in HNSCC compared to CPS.
  • Further understanding of TLS biology may lead to improved patient selection for ICB therapy.